Testing effectiveness (Phase 2)Study completedNCT03616184
What this trial is testing
Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
Who this might be right for
Graft-versus-host-disease (GVHD)
University of Nebraska 49